Exelixis Inc (EXEL)
21.74
-0.22
(-1.00%)
USD |
NASDAQ |
Jun 14, 16:00
21.74
0.00 (0.00%)
After-Hours: 20:00
Exelixis Total Return Level: 21.74 for June 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 14, 2024 | 21.74 |
June 13, 2024 | 21.96 |
June 12, 2024 | 22.06 |
June 11, 2024 | 22.03 |
June 10, 2024 | 22.13 |
June 07, 2024 | 21.88 |
June 06, 2024 | 22.18 |
June 05, 2024 | 21.96 |
June 04, 2024 | 21.74 |
June 03, 2024 | 21.93 |
May 31, 2024 | 21.69 |
May 30, 2024 | 20.78 |
May 29, 2024 | 20.49 |
May 28, 2024 | 20.34 |
May 24, 2024 | 20.57 |
May 23, 2024 | 20.41 |
May 22, 2024 | 21.00 |
May 21, 2024 | 21.02 |
May 20, 2024 | 21.06 |
May 17, 2024 | 20.91 |
May 16, 2024 | 21.23 |
May 15, 2024 | 21.12 |
May 14, 2024 | 20.99 |
May 13, 2024 | 21.27 |
May 10, 2024 | 21.37 |
Date | Value |
---|---|
May 09, 2024 | 21.76 |
May 08, 2024 | 21.59 |
May 07, 2024 | 22.15 |
May 06, 2024 | 21.90 |
May 03, 2024 | 21.90 |
May 02, 2024 | 22.12 |
May 01, 2024 | 21.92 |
April 30, 2024 | 23.46 |
April 29, 2024 | 23.73 |
April 26, 2024 | 23.70 |
April 25, 2024 | 23.53 |
April 24, 2024 | 23.71 |
April 23, 2024 | 23.29 |
April 22, 2024 | 22.87 |
April 19, 2024 | 22.52 |
April 18, 2024 | 22.49 |
April 17, 2024 | 22.87 |
April 16, 2024 | 22.82 |
April 15, 2024 | 22.70 |
April 12, 2024 | 22.81 |
April 11, 2024 | 22.65 |
April 10, 2024 | 23.68 |
April 09, 2024 | 23.72 |
April 08, 2024 | 23.35 |
April 05, 2024 | 23.14 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
14.46
Minimum
Mar 16 2020
27.42
Maximum
May 11 2020
20.29
Average
20.45
Median
Jul 08 2019
Total Return Level Benchmarks
Incyte Corp | 62.11 |
Regeneron Pharmaceuticals Inc | 1036.52 |
Iovance Biotherapeutics Inc | 8.16 |
Blueprint Medicines Corp | 105.55 |
Arcus Biosciences Inc | 16.97 |